FOXO Technologies ( (FOXO) ) has shared an announcement.
Rennova Health, Inc. and its subsidiary engaged in a strategic transaction involving a stock exchange agreement with another company, amending the original terms to include a cash consideration and a $22 million senior note, secured by assets and guaranteed by the involved companies. The note, with a two-year maturity and a tiered interest rate, mandates repayments based on free cash flow and can be offset by future equity capital proceeds. Additionally, the company’s board of directors has been expanded with two new appointments, bringing valuable experience in healthcare and financial consulting to the team.
For detailed information about FOXO stock, go to TipRanks’ Stock Analysis page.
